10 High Growth Forever Dividend Stocks To Invest In

5. AbbVie Inc. (NYSE:ABBV)

5-Year Revenue Growth: 11.11%

AbbVie Inc. (NYSE:ABBV) ranks fifth on our list of the best high growth forever dividend stocks. The American multinational pharmaceutical company has strengthened its portfolio in recent years through several key acquisitions, adding significant growth assets such as the cancer drug Elahere, the cosmetic treatment Botox, and the antipsychotic medication Vraylar.

AbbVie Inc. (NYSE:ABBV)’s development pipeline also shows promise, with more than 90 programs currently in clinical trials. Among them are advanced-stage candidates like lutikizumab for autoimmune conditions and etentamig for multiple myeloma.

In the fourth quarter of 2025, AbbVie Inc. (NYSE:ABBV) posted revenue of $15.1 billion, reflecting a 5.6% increase year-over-year and surpassing analyst forecasts by $14.87 billion. Although the company reported a slight GAAP net loss of $0.02 per share, its adjusted diluted earnings per share came in at $2.16, just above the projected $2.13. For the full year 2024, combined sales of Skyrizi and Rinvoq climbed 51% to $1.77 billion, driven by rising global demand and broader market reach.

AbbVie Inc. (NYSE:ABBV)’s quarterly dividend currently stands at $1.64 per share for a dividend yield of 3.75%, as of April 13. The company has rewarded shareholders with growing dividends for the past 52 consecutive years.